Merck & Co., Inc. NYSE: MRK has filed 13-F forms with the SEC as an investor. Merck & Co., Inc. is itself a publicly traded company. Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. For more information on Merck & Co., Inc. stock, visit the Merck & Co., Inc. stock profile here.
Investment Activity
- Merck & Co., Inc. has $349.44 million in total holdings as of June 30, 2025.
- Merck & Co., Inc. owns shares of 14 different stocks, but just 4 companies or ETFs make up 80% of its holdings.
- Approximately 10.18% of the portfolio was purchased this quarter.
- About 0.27% of the portfolio was sold this quarter.
- This quarter, Merck & Co., Inc. has purchased 12 new stocks and bought additional shares in 1 stock.
- Merck & Co., Inc. sold shares of 0 stocks and completely divested from 1 stock this quarter.
Largest Holdings
- ENTRADA THERAPEUTICS INC
- $21,955,872
- EIKON THERAPEUTICS INC
- $17,633,326
Largest New Holdings this Quarter
- 282564103 - EIKON THERAPEUTICS INC
- $17,633,326 Holding
- 01021M104 - AKTIS ONCOLOGY INC
- $17,046,379 Holding
- 98422T209 - XILIO THERAPEUTICS INC
- $891,309 Holding
Largest Purchases this Quarter
- EIKON THERAPEUTICS INC
- 1,666,666 shares (about $17.63M)
- AKTIS ONCOLOGY INC
- 952,844 shares (about $17.05M)
- XILIO THERAPEUTICS INC
- 105,982 shares (about $891.31K)
- TUHURA BIOSCIENCES
- 5,495 shares (about $9.84K)
